Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · IEX Real-Time Price · USD
3.090
-0.130 (-4.04%)
At close: Jul 19, 2024, 4:30 PM
3.080
-0.010 (-0.32%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $98.61 million as of July 22, 2024.
Market Cap
98.61M
Enterprise Value
-95.07M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $98.61M, a decrease of -72.21%. That is a compound annual growth rate of -71.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 98.60M | -20.55% |
| Dec 29, 2023 | 124.10M | -65.02% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adicet Bio | 101.90M |
| Cardiff Oncology | 100.63M |
| So-Young International | 98.92M |
| VistaGen Therapeutics | 98.91M |
| Omega Therapeutics | 98.73M |
| Sensus Healthcare | 98.36M |
| Xtant Medical Holdings | 96.53M |
| Checkpoint Therapeutics | 96.44M |